Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
02/2015
02/18/2015EP2836502A1 A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3beta-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS
02/17/2015CA2710977C 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
02/12/2015WO2015018757A1 25-oh vitamin d derivatives for determination of vitamin d metabolites
02/12/2015DE102013215580A1 25-OH Vitamin D Derivate zur Bestimmung von Vitamin D Metaboliten 25-OH vitamin D derivatives for the determination of vitamin D metabolites
01/2015
01/27/2015US8940916 Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
01/14/2015EP2823810A1 Amphoteric liposomes comprising imino lipids
12/2014
12/17/2014CN104220450A 用于治疗代谢障碍、高脂血症、糖尿病、月旨肪肝疾病和动脉粥样硬化的新的胆固醇代谢物5-胆甾烯-3e，25-二醇二硫酸酯（25HCDS) For the treatment of metabolic disorders, hyperlipidemia, diabetes, fatty liver disease and aims month atherosclerosis new cholesterol metabolite 5- cholesteryl -3e, 25- glycol disulfate (25HCDS)
12/17/2014CN104211626A 新型维生素d受体活化剂及制造方法 The new vitamin d receptor activation and manufacturing method
12/09/2014US8906888 Low-calcemic 16,23-diene 25-oxime analogs of 1α,25-dihydroxy vitamin D3
11/2014
11/11/2014US8884039 Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
10/2014
10/09/2014WO2014165232A1 Compounds for treatment of cancer
10/07/2014US8853188 Compositions and methods for cancer treatment
09/2014
09/25/2014DE102013205055A1 Verfahren und Reagenz zur Bestimmung von Vitamin D Metaboliten Method and reagent for the determination of vitamin D metabolites
09/04/2014US20140248707 Release reagent for vitamin d compounds
08/2014
08/27/2014EP2768804A1 2-methylene-vitamin d analogs and their uses
08/27/2014EP2768803A1 2-methylene-vitamin d analogs and their uses
08/13/2014CN103980173A 一种帕立骨化醇中间体的制备方法 A method for preparing legislation Pa calciferol intermediates
08/13/2014CN103980172A 一种1α,25-二羟基维生素D2的制备方法 One kind of 1α, 25- di hydroxy vitamin D2 in the preparation of
08/06/2014CN103965087A 帕立骨化醇关键中间体的合成工艺 Synthesis of paricalcitol key intermediates
08/05/2014US8796246 9, 10-secopregnane derivative and pharmaceutical
07/2014
07/31/2014WO2014116386A1 (22E)-2-METHYLENE-22-DEHYDRO-1α,24,25-TRIHYDROXY-19-NOR-VITAMIN D3 ANALOGS
07/24/2014US20140206655 (22e)-2-methylene-22-dehydro-1alpha,24,25-trihydroxy-19-nor-vitamin d3 analogs
07/23/2014CN102942431B 一种利用分子筛分离手性化合物的方法 A molecular sieve separation of chiral compounds utilizing methods
07/22/2014US8785422 A-ring modified 19-nor-vitamin D analogs and their uses
07/17/2014US20140200201 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
07/16/2014CN103922984A 西奥骨化醇的合成方法 Theo ossification alcohol synthesis method
07/09/2014EP2751075A1 Crystallization of 1 alpha-hydroxy-20-methylene-19,24,25,26,27-pentanorvitamin d3
07/09/2014CN103910666A 一种制备马沙骨化醇的方法 A method of preparing maxacalcitol
07/03/2014US20140187521 Amelioration of intestinal fibrosis and treatment of crohn's disease
07/02/2014CN103896817A 一种帕立骨化醇的制备方法 Li prepared a par ossification alcohol
06/2014
06/25/2014EP2746252A1 Crystallization of 1alpha-hydroxy-2-methylene- 18,19-dinor-homopregnacalciferol
06/24/2014US8759555 Stereoselective synthesis of vitamin D analogues
06/19/2014WO2014091046A1 Versatile and functionalised intermediates for the synthesis of vitamin d and novel vitamin d derivatives
06/17/2014US8754067 22-haloacetoxy-homopregnacalciferol analogs and their uses
05/2014
05/28/2014CN103819379A 维生素D<sub>3</sub>的胆甾烷醇共结晶及其制备方法和应用 Vitamin D <sub> 3 </ sub> of cholestanol co-crystallization and its preparation method and application
05/20/2014US8729054 3-desoxy-2-methylene-vitamin D analogs and their uses
04/2014
04/24/2014US20140113886 Stabilized 1, 25-Dihydroxyvitamin D2 and Method of Making Same
04/23/2014EP2721004A1 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
04/09/2014EP2714656A2 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
04/08/2014CA2653772C 9,10-secopregnane derivative and pharmaceutical
04/02/2014CN103694156A Preparation method of psoriasis therapeutic medicine calcipotriol
04/01/2014CA2637302C Vitamin d analog-rak, methods and uses thereof
03/2014
03/27/2014WO2014024210A3 Novel polymorphs of doxercalciferol
03/27/2014US20140088049 Method and apparatus for vitamin d enhancement in mushrooms
03/20/2014WO2013021138A3 Yeast flakes enriched with vitamin d2, compositions containing same, method for preparing same, uses thereof, and device for implementing the method
03/04/2014US8664206 Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
02/2014
02/20/2014US20140051875 Crystalline form of maxacalcitol
02/19/2014CN103588689A Crystalline form of maxacalcitol
02/13/2014WO2014024210A2 Novel polymorphs of doxercalciferol
02/06/2014US20140038925 Novel Vitamin D Receptor Modulators with Partial Agonist Activity
02/05/2014CN103553993A Method for synthesizing resinous vitamin D3 by using micro-flow photoreaction technology and micro-flow photochemical reactor
02/04/2014US8642579 1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
01/2014
01/15/2014CN103508999A Maxacalcitol synthesizing intermediate and preparation method and application thereof
01/09/2014US20140011778 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3
01/08/2014EP2682386A1 Novel vitamin d receptor modulator with partial agonist activity
12/2013
12/24/2013US8614202 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses
12/18/2013CN103451238A Method for preparing paricalcitol
12/17/2013US8609643 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs
12/12/2013WO2013184412A1 A-ring modified 19-nor-vitamin d analogs and their uses
12/12/2013US20130331459 A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses
12/10/2013US8604009 (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3
12/10/2013US8604008 2-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferol
12/05/2013WO2013180882A1 CRYSTALLIZATION OF (20R)-19-NOR-24-DIFLUORO-1α,25-DIHYDROXYVITAMIN D3
12/05/2013WO2013180881A1 CRYSTALLIZATION OF (20R,22R)-2-METHYLENE-19-NOR-22-METHYL-1α,25-DIHYDROXYVITAMIN D3 AND RELATED PRECURSORS
12/05/2013WO2013180880A1 CRYSTALLIZATION OF (20R)-2-METHYLENE-19-NOR-24-DIFLUORO-1α, 25-DIHYDROXYVITAMIN D3
12/05/2013WO2013180879A1 Crystallization of (20r) and (20s) analogs of 2-methylene-19-nor-22-dimethyl-1alpha,25-dihydroxyvitamin d3
12/05/2013US20130324752 Crystallization of (20R,22R)-2-Methylene-19-Nor-22-Methyl-1alpha,25-Dihydroxyvitamin D3 and Related Precursors
12/05/2013US20130324751 Crystallization of (20R) 19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3
12/05/2013US20130324750 Crystallization of (20R)-2-Methylene-19-Nor-24-Difluoro-1alpha,25-Dihydroxyvitamin D3
12/05/2013US20130324749 Crystallization of (20R) and (20S) Analogs of 2-Methylene-19-Nor-24-Dimethyl-1alpha,25-Dihydroxyvitamin D3
11/2013
11/13/2013CN101863809B Method for purifying doxercalciferol
11/06/2013CN102558006B Method for separating vitamin D3 from tachysterol T3
11/05/2013US8575136 2-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof
10/2013
10/30/2013CN101671288B Preparation method of intermediate of paricalcitol
10/17/2013WO2013154752A1 A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3β-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS
09/2013
09/04/2013EP2634171A1 23-yne-vitamin d3 derivative
08/2013
08/28/2013EP2630121A1 (20r,25s)-2-methylene-19,26-dinor-1alpha, 25-dihydroxyvitamin d3 in crystalline form
08/27/2013US8519169 Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3
08/27/2013US8518917 2-methylene-19-nor-vitamin D analogs and their uses
08/15/2013US20130210781 23-yne-vitamin d3 derivative
08/07/2013CN103232374A Side-chain aromatic ring-modified active vitamin D3 analog, as well as preparation method and application thereof
07/2013
07/11/2013US20130178449 2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs
07/10/2013CN101880253B Preparation method of paricalcitol
07/04/2013US20130172588 Continuous photolytic process for the preparation of vitamin d related substances
07/02/2013CA2481909C Preparation of 24-alkyl analogs of cholecalciferol
06/2013
06/26/2013CN103180293A 23-yne-vitamin D3 derivative
06/20/2013US20130157987 1-deoxy analogs of 1,25-dihydroxyvitamin d3 compounds
06/19/2013CN103159657A Method for rationally synthesizing unsaturated conjugated alcohol
06/19/2013CN103159656A Preparation method of calcitriol
06/04/2013US8455467 2-methylene-vitamin D analogs and their uses
06/04/2013US8455466 Vitamin d analogues, compositions comprising said analogues and their use
05/2013
05/29/2013CN101405249B Process for production of indene derivative, and intermediate for production of the derivative
05/21/2013US8445468 (20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3
05/14/2013US8440647 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses
05/08/2013CN103086937A Method for synthesizing paricalcitol
05/08/2013CN101830840B Method for producing vitamin D3
05/07/2013CA2646856C Isomerisation of pharmaceutical intermediates
05/01/2013CN103073469A Preparation method for alfacalcidol
05/01/2013CN103073468A Synthetic method of osteoporosis treatment drug 1 alpha-hydroxyitamin D3
04/2013
04/25/2013WO2013059060A1 2-methylene-vitamin d analogs and their uses
1 2 3 4 5 6 7 8 9 10 11 ... 35